Anti-STIM2 monoclonal antibody

Anti-STIM2 antibody for FACS & in-vivo assay

Target products collectionGo to STIM2/STIM2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1717-Ab-1/ GM-Tg-hg-MP1717-Ab-2Anti-Human STIM2 monoclonal antibodyHuman
GM-Tg-rg-MP1717-Ab-1/ GM-Tg-rg-MP1717-Ab-2Anti-Rat STIM2 monoclonal antibodyRat
GM-Tg-mg-MP1717-Ab-1/ GM-Tg-mg-MP1717-Ab-2Anti-Mouse STIM2 monoclonal antibodyMouse
GM-Tg-cynog-MP1717-Ab-1/ GM-Tg-cynog-MP1717-Ab-2Anti-Cynomolgus/ Rhesus macaque STIM2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1717-Ab-1/ GM-Tg-felg-MP1717-Ab-2Anti-Feline STIM2 monoclonal antibodyFeline
GM-Tg-cang-MP1717-Ab-1/ GM-Tg-cang-MP1717-Ab-2Anti-Canine STIM2 monoclonal antibodyCanine
GM-Tg-bovg-MP1717-Ab-1/ GM-Tg-bovg-MP1717-Ab-2Anti-Bovine STIM2 monoclonal antibodyBovine
GM-Tg-equg-MP1717-Ab-1/ GM-Tg-equg-MP1717-Ab-2Anti-Equine STIM2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1717-Ab-1/ GM-Tg-hg-MP1717-Ab-2; GM-Tg-rg-MP1717-Ab-1/ GM-Tg-rg-MP1717-Ab-2;
GM-Tg-mg-MP1717-Ab-1/ GM-Tg-mg-MP1717-Ab-2; GM-Tg-cynog-MP1717-Ab-1/ GM-Tg-cynog-MP1717-Ab-2;
GM-Tg-felg-MP1717-Ab-1/ GM-Tg-felg-MP1717-Ab-2; GM-Tg-cang-MP1717-Ab-1/ GM-Tg-cang-MP1717-Ab-2;
GM-Tg-bovg-MP1717-Ab-1/ GM-Tg-bovg-MP1717-Ab-2; GM-Tg-equg-MP1717-Ab-1/ GM-Tg-equg-MP1717-Ab-2
Products NameAnti-STIM2 monoclonal antibody
Formatmab
Target NameSTIM2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-STIM2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species STIM2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1717
    Target NameSTIM2
    Gene ID57620,116873,117087,694980,479120,101100466,541299,100066682
    Gene Symbol and SynonymsSTIM2
    Uniprot AccessionQ9P246
    Uniprot Entry NameSTIM2_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000109689
    Target ClassificationN/A

    The target: STIM2, gene name: STIM2, also named as . This gene is a member of the stromal interaction molecule (STIM) family and likely arose, along with related family member STIM1, from a common ancestral gene. The encoded protein functions to regulate calcium concentrations in the cytosol and endoplasmic reticulum, and is involved in the activation of plasma membrane Orai Ca(2+) entry channels. This gene initiates translation from a non-AUG (UUG) start site. A signal peptide is cleaved from the resulting protein. Multiple transcript variants result from alternative splicing. [provided by RefSeq, Dec 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.